BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 22023617)

  • 1. Erythropoietin and Wnt1 govern pathways of mTOR, Apaf-1, and XIAP in inflammatory microglia.
    Shang YC; Chong ZZ; Wang S; Maiese K
    Curr Neurovasc Res; 2011 Nov; 8(4):270-85. PubMed ID: 22023617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular injury during elevated glucose can be mitigated by erythropoietin and Wnt signaling.
    Chong ZZ; Shang YC; Maiese K
    Curr Neurovasc Res; 2007 Aug; 4(3):194-204. PubMed ID: 17691973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of β-amyloid degeneration of microglia by erythropoietin depends on Wnt1, the PI 3-K/mTOR pathway, Bad, and Bcl-xL.
    Shang YC; Chong ZZ; Wang S; Maiese K
    Aging (Albany NY); 2012 Mar; 4(3):187-201. PubMed ID: 22388478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pro-survival pathways of mTOR and protein kinase B target glycogen synthase kinase-3beta and nuclear factor-kappaB to foster endogenous microglial cell protection.
    Chong ZZ; Li F; Maiese K
    Int J Mol Med; 2007 Feb; 19(2):263-72. PubMed ID: 17203200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wnt1, FoxO3a, and NF-kappaB oversee microglial integrity and activation during oxidant stress.
    Shang YC; Chong ZZ; Hou J; Maiese K
    Cell Signal; 2010 Sep; 22(9):1317-29. PubMed ID: 20462515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microglial integrity is maintained by erythropoietin through integration of Akt and its substrates of glycogen synthase kinase-3beta, beta-catenin, and nuclear factor-kappaB.
    Li F; Chong ZZ; Maiese K
    Curr Neurovasc Res; 2006 Aug; 3(3):187-201. PubMed ID: 16918383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythropoietin prevents early and late neuronal demise through modulation of Akt1 and induction of caspase 1, 3, and 8.
    Chong ZZ; Lin SH; Kang JQ; Maiese K
    J Neurosci Res; 2003 Mar; 71(5):659-69. PubMed ID: 12584724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythropoietin is a novel vascular protectant through activation of Akt1 and mitochondrial modulation of cysteine proteases.
    Chong ZZ; Kang JQ; Maiese K
    Circulation; 2002 Dec; 106(23):2973-9. PubMed ID: 12460881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EPO relies upon novel signaling of Wnt1 that requires Akt1, FoxO3a, GSK-3β, and β-catenin to foster vascular integrity during experimental diabetes.
    Chong ZZ; Hou J; Shang YC; Wang S; Maiese K
    Curr Neurovasc Res; 2011 May; 8(2):103-20. PubMed ID: 21443457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wnt1 neuroprotection translates into improved neurological function during oxidant stress and cerebral ischemia through AKT1 and mitochondrial apoptotic pathways.
    Chong ZZ; Shang YC; Hou J; Maiese K
    Oxid Med Cell Longev; 2010; 3(2):153-65. PubMed ID: 20716939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythropoietin fosters both intrinsic and extrinsic neuronal protection through modulation of microglia, Akt1, Bad, and caspase-mediated pathways.
    Chong ZZ; Kang JQ; Maiese K
    Br J Pharmacol; 2003 Mar; 138(6):1107-18. PubMed ID: 12684267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular demise and inflammatory microglial activation during beta-amyloid toxicity are governed by Wnt1 and canonical signaling pathways.
    Chong ZZ; Li F; Maiese K
    Cell Signal; 2007 Jun; 19(6):1150-62. PubMed ID: 17289346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apaf-1, Bcl-xL, cytochrome c, and caspase-9 form the critical elements for cerebral vascular protection by erythropoietin.
    Chong ZZ; Kang JQ; Maiese K
    J Cereb Blood Flow Metab; 2003 Mar; 23(3):320-30. PubMed ID: 12621307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PRAS40 is an integral regulatory component of erythropoietin mTOR signaling and cytoprotection.
    Chong ZZ; Shang YC; Wang S; Maiese K
    PLoS One; 2012; 7(9):e45456. PubMed ID: 23029019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. mGluRI targets microglial activation and selectively prevents neuronal cell engulfment through Akt and caspase dependent pathways.
    Chong ZZ; Kang J; Li F; Maiese K
    Curr Neurovasc Res; 2005 Jul; 2(3):197-211. PubMed ID: 16181114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythropoietin: new directions for the nervous system.
    Maiese K; Chong ZZ; Shang YC; Wang S
    Int J Mol Sci; 2012; 13(9):11102-11129. PubMed ID: 23109841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting WNT, protein kinase B, and mitochondrial membrane integrity to foster cellular survival in the nervous system.
    Chong ZZ; Maiese K
    Histol Histopathol; 2004 Apr; 19(2):495-504. PubMed ID: 15024710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FoxO3a governs early microglial proliferation and employs mitochondrial depolarization with caspase 3, 8, and 9 cleavage during oxidant induced apoptosis.
    Shang YC; Chong ZZ; Hou J; Maiese K
    Curr Neurovasc Res; 2009 Nov; 6(4):223-38. PubMed ID: 19807657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythropoietin requires NF-kappaB and its nuclear translocation to prevent early and late apoptotic neuronal injury during beta-amyloid toxicity.
    Chong ZZ; Li F; Maiese K
    Curr Neurovasc Res; 2005 Dec; 2(5):387-99. PubMed ID: 16375720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wnt1 inducible signaling pathway protein 1 (WISP1) blocks neurodegeneration through phosphoinositide 3 kinase/Akt1 and apoptotic mitochondrial signaling involving Bad, Bax, Bim, and Bcl-xL.
    Wang S; Chong ZZ; Shang YC; Maiese K
    Curr Neurovasc Res; 2012 Feb; 9(1):20-31. PubMed ID: 22272766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.